Robert J Chilton

  • 8340 Citations
  • 25 h-Index
1980 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

PCSK9 inhibitors and diabetes: Translational biology to clinical practice

Chilton, R. J., Oliveros, R., Gallegos, K. M. & Pham, S., Jan 1 2019, (Accepted/In press) In : Diabetes, Obesity and Metabolism.

Research output: Contribution to journalArticle

2018

Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes

Marso, S. P., Hardy, E., Han, J., Wang, H. & Chilton, R. J., Apr 1 2018, In : Diabetes Therapy. 9, 2, p. 551-564 14 p.

Research output: Contribution to journalArticle

4 Scopus citations

Lipids as risk markers for type 2 diabetes

Bloomgarden, Z. & Chilton, R. J., Jan 1 2018, (Accepted/In press) In : Journal of Diabetes.

Research output: Contribution to journalArticle

1 Scopus citations

Myocardial considerations in type 2 diabetes: 2018

Chilton, R., Lin, C., Gallegos, K. M. & Pham, S., Jan 1 2018, (Accepted/In press) In : Journal of Diabetes.

Research output: Contribution to journalArticle

1 Scopus citations

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

COMPASS investigators, Jan 20 2018, In : The Lancet. 391, 10117, p. 205-218 14 p.

Research output: Contribution to journalArticle

135 Scopus citations

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

COMPASS investigators, Jan 20 2018, In : The Lancet. 391, 10117, p. 219-229 11 p.

Research output: Contribution to journalArticle

250 Scopus citations
2017

A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes

Jax, T., Stirban, A., Terjung, A., Esmaeili, H., Berk, A., Thiemann, S., Chilton, R., Eynatten, M. & Marx, N., Jan 21 2017, In : Cardiovascular Diabetology. 16, 1, 13.

Research output: Contribution to journalArticle

20 Scopus citations

EMPA-REG OUTCOME: The Cardiologist's Point of View

Pham, S. V. & Chilton, R., 2017, (Accepted/In press) In : American Journal of Medicine.

Research output: Contribution to journalArticle

8 Scopus citations

EMPA-REG OUTCOME: The Cardiologist's Point of View

Pham, S. V. & Chilton, R. J., Jul 1 2017, In : American Journal of Cardiology. 120, 1, p. S53-S58

Research output: Contribution to journalArticle

9 Scopus citations

Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension

Chilton, R., Tikkanen, I., Hehnke, U., Woerle, H. J. & Johansen, O. E., Nov 2017, In : Diabetes, Obesity and Metabolism. 19, 11, p. 1620-1624 5 p.

Research output: Contribution to journalArticle

12 Scopus citations

Introduction

Chilton, R. J., 2017, (Accepted/In press) In : American Journal of Medicine.

Research output: Contribution to journalArticle

Pioglitazone improves left ventricular diastolic function in subjects with diabetes

Clarke, G. D., Solis-Herrera, C., Molina-Wilkins, M., Martinez, S., Merovci, A., Cersosimo, E., Chilton, R. J., Iozzo, P., Gastaldelli, A., Abdul-ghani, M. A. & Defronzo, R. A., Nov 1 2017, In : Diabetes Care. 40, 11, p. 1530-1536 7 p.

Research output: Contribution to journalArticle

17 Scopus citations

Rivaroxaban with or without aspirin in stable cardiovascular disease

COMPASS investigators, Oct 5 2017, In : New England Journal of Medicine. 377, 14, p. 1319-1330 12 p.

Research output: Contribution to journalArticle

678 Scopus citations
2016

Cardiac manifestations of congenital generalized lipodystrophy

Sanon, V. P., Handelsman, Y., Pham, S. V. & Chilton, R., 2016, In : Clinical Diabetes. 34, 4, p. 181-186 6 p.

Research output: Contribution to journalArticle

8 Scopus citations

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

Neeland, I. J., McGuire, D. K., Chilton, R. J., Crowe, S., Lund, S. S., Woerle, H. J., Broedl, U. C. & Johansen, O. E., Mar 1 2016, In : Diabetes and Vascular Disease Research. 13, 2, p. 119-126 8 p.

Research output: Contribution to journalArticle

60 Scopus citations

Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension

Tikkanen, I., Chilton, R. J. & Johansen, O. E., Mar 1 2016, In : Current Opinion in Nephrology and Hypertension. 25, 2, p. 81-86 6 p.

Research output: Contribution to journalArticle

24 Scopus citations

Revitalization of pioglitazone: The optimum agent to be combined with a sodium-glucose co-transporter-2 inhibitor

Defronzo, R. A., Chilton, R. J., Norton, L., Clarke, G. D., Ryder, R. E. J. & Abdul-ghani, M. A., May 1 2016, In : Diabetes, Obesity and Metabolism. 18, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

25 Scopus citations

SGLT2 inhibitors and cardiovascular risk: Lessons learned from the EMPA-REG Outcome study

Abdul-ghani, M. A., Del Prato, S., Chilton, R. J. & Defronzo, R. A., May 1 2016, In : Diabetes Care. 39, 5, p. 717-725 9 p.

Research output: Contribution to journalArticle

168 Scopus citations
2015

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

Chilton, R., Tikkanen, I., Cannon, C. P., Crowe, S., Woerle, H. J., Broedl, U. C. & Johansen, O. E., Dec 2015, In : Diabetes, Obesity and Metabolism. 17, 12, p. 1180-1193 14 p.

Research output: Contribution to journalArticle

194 Scopus citations
2014

Does dipeptidyl peptidase IV inhibitor increase the risk of heart failure? A cardiologist's paradox

Kanakia, R., Martinho, S., Patel, T., Arain, F. A., Panday, M. M., Le Saux, C. J., Pham, S. V., Bailey, S. R. & Chilton, R., Dec 1 2014, In : Cardiovascular Endocrinology. 3, 4, p. 111-116 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

Integrative Computational and Experimental Approaches to Establish a Post-Myocardial Infarction Knowledge Map

Nguyen, N. T., Zhang, X., Wu, C., Lange, R. A., Chilton, R. J., Lindsey, M. L. & Jin, Y. F., Mar 2014, In : PLoS computational biology. 10, 3, e1003472.

Research output: Contribution to journalArticle

8 Scopus citations

Proton-pump inhibitors in patients requiring antiplatelet therapy: New FDA labeling

Johnson, D. A., Chilton, R. & Liker, H. R., Jan 1 2014, In : Postgraduate medicine. 126, 3, p. 239-245 7 p.

Research output: Contribution to journalArticle

12 Scopus citations
2013

Glycemic control in type 2 diabetes: The tighter the better?

Pham, S., Phuong-Thu, T. & Chilton, R., Jan 31 2013, In : Clinical Diabetes. 31, 1, p. 25-27 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Left ventricular remodeling: One small step for the extracellular matrix will translate to a giant leap for the myocardium

Yabluchanskiy, A., Chilton, R. J. & Lindsey, M. L., Jul 1 2013, In : Congestive Heart Failure. 19, 4, p. E5-E8

Research output: Contribution to journalArticle

7 Scopus citations

Trading glucose control for hypertension: Lessons from mother nature

Chilton, R., Jan 31 2013, In : Clinical Diabetes. 31, 1, p. 21-24 4 p.

Research output: Contribution to journalArticle

2012

Acute coronary syndrome in patients with diabetes mellitus: Perspectives of an interventional cardiologist

Sanon, S., Patel, R., Eshelbrenner, C., Sanon, V. P., Alhaddad, M., Oliveros, R., Pham, S. V. & Chilton, R., Nov 6 2012, In : American Journal of Cardiology. 110, SUPPL. 9, p. 13B-23B

Research output: Contribution to journalArticle

11 Scopus citations

Another telescope for examining statins: The SATURN trial

Patel, R. & Chilton, R. J., Jul 25 2012, In : Clinical Diabetes. 30, 3, p. 115-119 5 p.

Research output: Contribution to journalArticle

The Cardiovascular Effects of GLP-1 Receptor Agonists

Okerson, T. & Chilton, R. J., Jun 1 2012, In : Cardiovascular Therapeutics. 30, 3, p. e146-e155

Research output: Contribution to journalArticle

89 Scopus citations

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

Chiquette, E., Toth, P. P., Ramirez, G., Cobble, M. & Chilton, R., 2012, In : Vascular Health and Risk Management. 8, 1, p. 621-629 9 p.

Research output: Contribution to journalArticle

31 Scopus citations
2011

Cardiovascular comorbidities of type 2 diabetes mellitus: Defining the potential of glucagonlike peptide1-based therapies

Chilton, R., Wyatt, J., Nandish, S., Oliveros, R. & Lujan, M., Jan 1 2011, In : American Journal of Medicine. 124, 1 SUPPL., p. S35-S53

Research output: Contribution to journalArticle

53 Scopus citations

Reducing cardiovascular events and end-organ damage in patients with hypertension: New considerations

Harmon, L., Chilton, R. J. & Spellman, C., Mar 1 2011, In : Postgraduate medicine. 123, 2, p. 7-17 11 p.

Research output: Contribution to journalArticle

4 Scopus citations
2010
Open Access
73 Scopus citations
2009

GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects

Sulistio, M., Carothers, C., Mangat, M., Lujan, M., Oliveros, R. & Chilton, R., Mar 2 2009, In : Current atherosclerosis reports. 11, 2, p. 93-99 7 p.

Research output: Contribution to journalArticle

22 Scopus citations

Silent myocardial ischemia: Diagnosis, treatment, and prognosis

Moore, T. D., Witte, A. P. & Chilton, R., Feb 1 2009, In : Consultant. 49, 2

Research output: Contribution to journalArticle

1 Scopus citations
2007

Diabetic Endovascular Disease: Role of Coronary Artery Revascularization

Stone, K. E., Chiquette, E. & Chilton, R. J., Feb 16 2007, In : American Journal of Cardiology. 99, 4 SUPPL., p. 105-112 8 p.

Research output: Contribution to journalArticle

23 Scopus citations
2006

Aortic stenosis catheterization revisited: A long sheath single-puncture technique

Hays, J., Lujan, M. & Chilton, R., Jun 1 2006, In : Journal of Invasive Cardiology. 18, 6, p. 262-267 6 p.

Research output: Contribution to journalArticle

6 Scopus citations
2003

Lipid and nonlipid benefits of statins.

Chilton, R. J., Jul 2003, In : The Journal of the American Osteopathic Association. 103, 7 Suppl 3, p. S12-17

Research output: Contribution to journalArticle

4 Scopus citations

Other important applications for beta-blockers in high-risk patients.

Egan, B. M. & Chilton, R. J., Dec 2003, In : Postgraduate medicine. 114, 6 Suppl Role, p. 35-48 14 p.

Research output: Contribution to journalArticle

Type 2 diabetes, cardiovascular risk, and the link to insulin resistance

Stolar, M. W. & Chilton, R. J., Jan 1 2003, In : Clinical Therapeutics. 25, SUPPL. B, p. B4-B31

Research output: Contribution to journalArticle

50 Scopus citations
2002
1 Scopus citations
2001

Web alert.

Chilton, R., Jan 2001, In : Current atherosclerosis reports. 3, 1, 1 p.

Research output: Contribution to journalArticle

2000

Web alert.

Chilton, R., Jan 2000, In : Current atherosclerosis reports. 2, 1, p. 5-6 2 p.

Research output: Contribution to journalArticle

Web alert.

Chilton, R., Sep 1 2000, In : Current atherosclerosis reports. 2, 5, 1 p.

Research output: Contribution to journalArticle

Web alert.

Chilton, R., Jul 2000, In : Current atherosclerosis reports. 2, 4, 1 p.

Research output: Contribution to journalArticle

1999
29 Scopus citations

Web alert.

Chilton, R., Sep 1 1999, In : Current atherosclerosis reports. 1, 2, 1 p.

Research output: Contribution to journalArticle

Web alert.

Chilton, R., Jul 1 1999, In : Current atherosclerosis reports. 1, 1, 1 p.

Research output: Contribution to journalArticle